Literature DB >> 18805503

Marking time: the dynamic role of chromatin and covalent modification in transcription.

George Reid1, Rozenn Gallais, Raphaël Métivier.   

Abstract

The expression of genes subject to strict regulation can be a highly dynamic, cyclical process that sequentially achieves and then limits transcription. Kinetic investigations of the estrogen responsive pS2 (TFF1) promoter, to determine the occupancy of factors or the occurrence of covalent marks on chromatin, have provided the most comprehensive picture of the complexity of transcriptional cycling to date. Cycles are initiated by the assembly of intermediate transcription factors that in turn provoke conscription of the basal transcription machinery. These events then achieve activation of the polymerase II complex, which is subsequently followed by limitation of productivity through the action of repressive complexes. This latter phase resets the target promoter, through acting on chromatin structure, such that a subsequent cycle can be initiated. In consequence, transcription is dependent upon cis-acting elements (DNA and nucleosomes) that either interact with or are modified by trans-acting factors. Induced local structural changes to chromatin encompassing regulatory elements of gene promoters include alteration of the positional phasing of nucleosomes, substitution by variant histones, post-translational modification of nucleosomes, changes in the methylation of CpG dinucleotides and breaks in the sugar-phosphate backbone of DNA. A primary function of covalent modification of chromatin may be to drive a sequential progression of reversible interactions that achieve and regulate gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805503     DOI: 10.1016/j.biocel.2008.08.028

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  29 in total

Review 1.  Measurement of single-cell dynamics.

Authors:  David G Spiller; Christopher D Wood; David A Rand; Michael R H White
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

2.  The impact of transcriptional cycling on gene regulation.

Authors:  Carsten Carlberg
Journal:  Transcription       Date:  2010 Jul-Aug

3.  A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels.

Authors:  Tamzin M Tanner; Sarah Denayer; Bart Geverts; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Lien Spans; Vanessa Dubois; Adriaan B Houtsmuller; Frank Claessens; Annemie Haelens
Journal:  Cell Mol Life Sci       Date:  2010-02-26       Impact factor: 9.261

4.  Transcription stochasticity of complex gene regulation models.

Authors:  Anne Schwabe; Katja N Rybakova; Frank J Bruggeman
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

Review 5.  Epigenetic regulation of inducible gene expression in the immune system.

Authors:  Pek Siew Lim; Jasmine Li; Adele F Holloway; Sudha Rao
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

6.  Reconciling the concurrent fast and slow cycling of proteins on gene promoters.

Authors:  Yaolai Wang; Feng Liu; Jun Li; Wei Wang
Journal:  J R Soc Interface       Date:  2014-05-07       Impact factor: 4.118

7.  The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.

Authors:  Kristine M Hussey; Hongshan Chen; Christine Yang; Eugene Park; Nasun Hah; Hediye Erdjument-Bromage; Paul Tempst; Matthew J Gamble; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

Review 8.  What do expression dynamics tell us about the mechanism of transcription?

Authors:  Daniel R Larson
Journal:  Curr Opin Genet Dev       Date:  2011-08-19       Impact factor: 5.578

Review 9.  Eukaryotic transcriptional dynamics: from single molecules to cell populations.

Authors:  Antoine Coulon; Carson C Chow; Robert H Singer; Daniel R Larson
Journal:  Nat Rev Genet       Date:  2013-07-09       Impact factor: 53.242

10.  Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

Authors:  Stephanie L Nott; Yanfang Huang; Aja Kalkanoglu; Kathryn Harper; Ming Chen; Scott F Paoni; Bruce M Fenton; Mesut Muyan
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.